TCL Archive DeVita To continue Discussions On Expanded Chops Despite ACCC Coolness; Would Go To DRCCA Board March 27, 1981
TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program November 1, 1985